Filing Details

Accession Number:
0000899243-22-011614
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-18 18:40:21
Reporting Period:
2022-03-17
Accepted Time:
2022-03-18 18:40:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529655 Charles Gary Robb C/O Corcept Therapeutics Incorporated
149 Commonwealth Drive
Menlo Park CA 94025
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-17 7,512 $24.68 76,434 No 4 S Direct
Common Stock Disposition 2022-03-18 4,988 $24.67 71,446 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,814 Indirect Custodial account for child
Common Stock 5,814 Indirect Custodial account for child
Common Stock 5,814 Indirect Custodial account for child
Footnotes
  1. The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.67 to $24.70. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
  3. These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.